Adeno-associated virus (AAV) is a single-stranded parvovirus retaining the unique capacity for site-specific integration into a transcriptionally silent region of the human genome, a characteristic requiring the functional properties of the Rep 78/68 polypeptide in conjunction with AAV terminal repeat integrating elements. Previous strategies designed to assemble these genetic elements into adenoviral (Ad) backbones have been limited by the general intolerability of AAV Rep sequences, prompting us to computationally reengineer the Rep gene by using synonymous codon pair recoding. Rep mutants generated by using de novo genome synthesis maintained the polypeptide sequence and endonuclease properties of Rep 78, while dramatically enhancing Ad replication and viral titer yields, characteristics indistinguishable from adenovirus lacking coexpressed Rep. Parallel approaches using domain swaps encompassing WT and recoded genomic segments, coupled with iterative computational algorithms, collectively established that 3′ cis-acting Rep genetic elements (and not the Rep 78 polypeptide) retain dominant-acting sequences inhibiting Ad replication. These data provide insights into the molecular relationships of AAV Rep and Ad replication, while expanding the applicability of synonymous codon pair reengineering as a strategy to effect phenotypic endpoints.codon pair bias | gene therapy | hybrid virus | systems biology A deno-associated virus (AAV) is a nonpathogenic singlestranded parvovirus that displays the unique capacity for sitespecific integration into the transcriptionally silent AAVS1 region of the human genome located on 19q13.42 (1, 2). The small 4.7-kb AAV genome encodes three structural capsid (VP1-VP3) and four nonstructural replication (Rep) proteins translated from two ORFs, and transcriptionally regulated by p5 (Rep 78 and Rep 68), p19 (Rep 52 and Rep 40), and p40 (VP1-VP3) promoters (reviewed in ref.3). Productive AAV infection requires helper functions generally supplied by adenovirus (Ad) or herpesvirus, and latency likely occurs by nonhomologous deletion/substitution events (4-6), resulting in head-to-tail stably integrated concatemers (7,8). AAV-mediated site-specific integration requires AAV Rep 78/68 delivered in trans (9), a cis-acting Rep-binding element found within the flanking terminal repeats (TRs) (10), and a restricted 33-bp cellular sequence within AAVS1 (5). Recent data have implicated a 138-bp integration efficiency element (i.e., p5IEE) within the p5 promoter as being sufficient and necessary for efficient Rep 78/68-mediated site-specific integration (11).The incorporation of these AAV integrating elements into larger-capacity hybrid viruses represents a logical strategy for site-specific genetic replacement therapies of large transgenes. Although the AAV integrating elements (i.e., TRs or p5IEE) are readily incorporated into herpesvirus (12,13) (22), and colocalizes to Ad replication centers to prevent their maturation (23). Furthermore, the complexity of these relationships is highlighted b...